We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




MRI is Superior to MDCT for Detecting Endoleaks

By MedImaging staff writers
Posted on 05 May 2008
Contrast-enhanced magnetic resonance imaging (MRI) is considerably better than 16-slice multidetector computed tomography (MDCD) in the detection of endoleaks after endovascular repair of abdominal aortic aneurisms (EVAR), according to a recent study.

"Endovascular repair of abdominal aortic aneurysms has become a viable alternative treatment to open surgery for many patients. More...
Endoleak development represents a complication of endovascular aortic aneurysm repair and is characterized by blood flow outside the stent-graft lumen but within the aneurysm sac,” said Rolf Wyttenbach, M.D., from the Ospedale San Giovanni (Bellinzona, Switzerland) and lead author of the study. "Patients after EVAR need livelong imaging surveillance to detect endoleaks. CT is most commonly used for imaging follow-up of these patients. A few prior studies suggested that MRI might be superior to CT for the detection of endoleaks. However, these studies mostly used single or four-row MDCT and standard gadolinium contrast media for MR imaging,” he said.

The study consisted of 43 patients who had undergone EVAR. Each of the patients had both MDCT and MRI within one week of the procedure. According to the researchers, MRI was performed using a high relaxivity contrast medium and for MDCT, an iodine-containing agent was used. Upon the completion of the study, two observers evaluated MRI and MDCT separately.

The study revealed that 21 endoleaks were detected in 18 patients. Sensitivity, specificity and accuracy for endoleak detection were 100%, 96%, and 98%, respectively, for reader 1 and 90%, 81% and 85% for reader 2, respectively, on MRI and 48%, 96%, and 74%, respectively, for both readers on MDCT.

"The results indicate that MR is a good choice for diagnosing endoleaks. Moreover, MRI does not expose the patients to radiation and the MR contrast agent is less nephrotoxic in the clinically used dose compared to iodinated contrast agents used for CT. For this reason MRI may become a preferred imaging modality to follow-up patients after endovascular aneurysm repair,” concluded Dr. Wyttenbach.

The findings of this study were presented April 15, 2008, during the American Roentgen Ray Society's annual meeting in Washington, DC, USA.


Related Links:
Ospedale San Giovanni

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.